Elicio Therapeutics Inc.

ELTX | NASDAQ

Price Alert Chart Builder DCF Calculator

$1.91

+$0.02 (+1.06%)

At close: Sep 21, 2026, 4:00 PM ET

$1.93

+$0.02 (+1.05%)

Pre-market: Sep 22, 2026, 9:09 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

+1.06%

(1D)

Rating

Updated: Sep 4, 2026

24.5

Fundamentals Weak

Market Sentiment Bullish

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $36.42M

1D Range

1.91 2.03

52W Range

1.71 16

Valuation (TTM)

PE -0.90

PB 4.59

EV/EBITDA -0.46

Valuation (NTM)

Forward PE N/A

Forward PEG -0.14

Price Target $11.83

Cash Flow

FCF Yield -103.5%

SBC Adj. FCF Yield -112.5%

SBC Impact -8.7%

Margins

Gross Margin 0.0%

Operating Margin 0.0%

FCF Margin N/A

Growth (CAGR)

Revenue 3Y | 5Y N/A | -100.0%

Dil EPS 3Y | 5Y 41.6% | 28.0%

FCF 3Y | 5Y -2.0% | -0.2%

Returns

ROA -120.8%

ROE -1266.4%

ROIC -163.4%

Financial Health

Net Cash

$18.87M

Current Ratio 2.77

Interest Coverage -24.00

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Elicio Therapeutics, Inc. is a clinical-stage biotechnology firm dedicated to creating a diverse array of innovative immunotherapies for the treatment of various cancers and other diseases. The compan...

Sector Healthcare

Industry Biotechnology

Employees 33

IPO Date Feb 4, 2021

Website elicio.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.

Analyst Summary

# of Analysts

Consensus

Hold

Price Target

$17

Upside

+790.05%

Buy (1)

Hold (1)

Sell (0)

Analyst Details ➞